Tag: coronavirus hospitalizations

US Intel Report Reveals No Incident Occurred at Wuhan Lab That Could Have Caused Pandemic, along with some observations and sarcasm

Tina Marie (Ms. Cat)

*But anonymous sources, at the State Department, told me that ‘patient zero’ had COVID-19! 🙄

Source.

Cleared by Congress, legislation later signed by US President Joe Biden in March ordered the Director of National Intelligence (DNI) to declassify information regarding the potential origins of SARS-CoV-2, the virus that causes COVID-19. The measure forced the DNI to declassify its report within 90 days.

US Intel Report Reveals No Incident Occurred at Wuhan Lab That Could Have Caused Pandemic

H/T: Unorthodox Truth

*Some observations: WCWP does not seem to prove that Ben Hu was ‘patient zero’. They link to a Daily Caller article, whose source is David Asher, who served in Trump’s State Department. He also happens to be a former Adjunct Senior Fellow at the ‘liberal’ hawkish think tank, Center for a New American Security. He’s currently a senior fellow at Hudson Institute and on the board of advisors of FDD’s Center on Economic and Financial Power (more neocon/hawkish think tanks). They also quote former FDA Commissioner, Dr. Scott Gottlieb, whom happens to be a Senior Fellow at the American Enterprise Institute (neocon think tank) and on the boards of directors for Illumina, Inc and Pfizer (Big Pharma). See a pattern, here?!

Related:

Ridiculous,’ says Chinese scientist accused of being pandemic’s patient zero (archived)

Hu and two of his WIV colleagues were thrown into the furious COVID-19 origin debate on 13 June when an online newsletter called Public said the three scientists developed COVID-19 in November 2019. That was prior to the outbreak becoming public when a cluster of cases at the end of December 2019 surfaced in people linked to a Wuhan marketplace. Public’s report was quickly embraced by a camp that argues COVID-19 came from a virus stored, and possibly manipulated, at WIV, rather than from infected animal hosts, perhaps being sold at the Wuhan market. A Wall Street Journal (WSJ) article on 20 June that said it had “confirmed” the allegations against the three, without referring to any public evidence or named sources with direct knowledge, fueled the flames even more. Social media and other publications spread the charges—and the scientists’ names.

Pfizer’s anti-COVID pill Paxlovid shows no benefit for younger adults

Tina Marie (Ms. Cat)

Pfizer’s anti-COVID pill Paxlovid shows no benefit for younger adults

The report’s authors found that Pfizer’s antiviral medication Paxlovid offered little to no benefit for younger adults. However, it did reduce the risk of hospitalization for high-risk seniors. Notably, supplementary material from the original study of Paxlovid in high-risk non-hospitalized adults with COVID-19 during the Delta wave had demonstrated benefits in those younger than 65, albeit the difference compared to the placebo was much less than in those 65 and older.

…

Among those over 65, there was a 73 percent decrease in the hospitalization rate and a 79 percent reduction in the risk of death. However, patients between the ages of 40 and 65 saw no benefit in taking the antiviral medication in either category, regardless of previous immunity status.

…

Another critical study from Hong Kong published in Lancet Infectious Diseases on the same day as the Israeli study but which went unmentioned in the press offered further evidence of Paxlovid’s limited therapeutic role. The authors reviewed their clinical experience with Paxlovid and Lagevrio, Merck’s antiviral pill, Molnupiravir, in hospitalized patients. They compared them to hospitalized patients who did not receive those medications during the horrific wave of infections that slammed into the semi-autonomous region in February and March.

…

The mortality risk reduction for Lagevrio was 52 percent, and for Paxlovid it was 66 percent. Those receiving antivirals had a lower risk of their disease progressing, but the drugs did not significantly impact their need for mechanical ventilation or ICU admission. The patients in the study averaged in age from mid-70s to early 80s.

…

Given the results of these studies, it bears mentioning that the Centers for Disease Control and Prevention (CDC) has recently estimated that approximately 95 percent of Americans aged 16 and older have some level of immunity against COVID-19.

Irony – The Bill & Melinda Gates Foundation partly funded a study about COVID-19 booster shots for the BA.5 Omicron subvariant. Surprise: Boosters still work

Tina Marie (Ms. Cat)1 Comment

The latest Omicron subvariant may be a master at evading the immune response our bodies produce from the vaccine or previous COVID-19 infection, but a new study suggests existing booster shots will still help.

The Bill & Melinda Gates Foundation partly funded a study about COVID-19 booster shots for the BA.5 Omicron subvariant. Surprise: Boosters still work

Isn’t it ironic?!

Biden tests positive for COVID-19, has ‘very mild symptoms’

Tina Marie (Ms. Cat)

By ZEKE MILLER and CHRIS MEGERIAN, Associated Press

WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 on Thursday and is experiencing “very mild symptoms,” the White House said, as new variants of the highly contagious virus are challenging the nation’s efforts to get back to normal after two and a half years of pandemic disruptions.

Biden tests positive for COVID-19, has ‘very mild symptoms’

DOUBLE-BOOSTED Fauci’s Covid WORSENS After Paxlovid Rebound.

Tina Marie (Ms. Cat)

Related:

Fauci Says He Had Paxlovid Rebound, Worse Symptoms:

Fauci first tested positive after having a “scratchy throat,” he told the newspaper. After taking Paxlovid, he was “surprised and disappointed” to see he tested positive again, and he had symptoms such as a low fever, achiness, runny nose, and “mild cough.” He then called his doctor, who prescribed another 5-day course of Paxlovid, which Fauci said is relatively common among those who have a rebound.

…

Earlier this month, Pfizer, the maker of Paxlovid, announced that it would stop adding new people to a clinical trial of the drug among COVID-19 patients who have a low risk of hospitalization and death. The study failed to show that the drug reduced symptoms, hospitalizations, or deaths in a statistically significant way, Bloomberg reported.

COVID-19 Rebound After Paxlovid Treatment:

There is currently no evidence that additional treatment is needed with Paxlovid or other anti-SARS-CoV-2 therapies in cases where COVID-19 rebound is suspected.

Going against CDC guidance, huh?! Hypocrite!

Why America Doesn’t Trust the CDC

Tina Marie (Ms. Cat)

Why America Doesn’t Trust the CDC

Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.

…

Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.